☆ 4.8 Editorial Material

Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE-AF

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study

Steven A. Lubitz et al.

Summary: Undiagnosed atrial fibrillation can be detected using a PPG algorithm on wearable devices. The algorithm has a high positive predictive value and can identify individuals at risk for atrial fibrillation.

CIRCULATION (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial

Konstantinos D. Rizas et al.

Summary: The study compared the efficacy of digital smart devices in detecting atrial fibrillation (AF) and found that digital screening technology more than doubled the detection rate of treatment-relevant AF compared to usual care. This technology has the potential for broad applicability and further studies are needed to assess if digital screening for AF leads to better treatment outcomes.

NATURE MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trial

Luisa Freyer et al.

Summary: This study aims to evaluate the effectiveness of an e-health-based strategy for atrial fibrillation detection in a real-world setting, compared to routine symptom-based screening. Approximately 67,488 policyholders of a large German health insurance company aged 50 and older with a CHA(2)DS(2)-VASc score of 1 or higher are invited to participate in this digital, prospective, randomized, siteless, open-label, cross-over study.

AMERICAN HEART JOURNAL (2021)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems